P

BPI 2026 · CDMO & CRO

ProBio at BPI 2026

ProBio brings 1 presentation to BPI 2026 in Boston, and exhibits at Booth 931. Its session covers CMC strategies for in vivo CAR-T therapies. The aim is cell therapies that are scalable, rapid to make and accessible.

OrganizationBPI 2026 Attendance
P
ProBio
1 Head of US Project Management
CDMO & CROBronze sponsor
CDMO, part of the GenScript group, serving biologics and cell and gene therapy developers with plasmid, viral vector and antibody development and manufacturing.
Booth
Exhibiting at Booth 931
Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm
Talk
Thu Sep 24
3:15pm–3:45pm
Unlocking the Promise of In Vivo CAR-T: CMC Strategies for Scalable, Rapid, and Accessible Cell Therapies
Development of Emerging Cell & Gene Therapies

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ProBio

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction